TABLE 7

Provisional Release Specifications for Sodium Pertechnetate 99mTc Injection Manufactured with Cyclotron

Parameter/traceTest methodProvisional specificationsValidation batches (n = 5)European PharmacopeiaU.S. Pharmacopeia
AppearanceVisualClear, colorlessConformClear, colorless
pHpH test strip4.0−8.05.0−5.54.0−8.04.5−7.5
Radiochemical identityThin-layer chromatographyRf > 0.7*0.8−0.9Rf ∼0.6Rf ∼0.9% ± 10%
Radiochemical purityThin-layer chromatography≥95%>98%≥95%≥95%
Radionuclidic identityγ-ray spectrometryγ ray at 141 keV141 keV140 keV140 keV
Radioisotopic purityγ-ray spectrometry>99.4%>99.98%>99.88%>99.935%
Other nuclides (not technetium)γ-ray spectrometryUndetectable γ ray at 569, 658, 740 keVConform≤0.12%≤0.065%
  • * Validated for silica-gel/acetone system; Rf for sodium pertechnetate in other systems may be different.

  • γ-ray peaks correspond to 96Nb (569 keV), 97Nb (658 keV), and 99Mo (740 keV).

  • Trace amounts of 99Mo, as well as other nontechnetium radionuclides, are permitted in 99mTc eluate.